{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:41:57Z","timestamp":1792618917465,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T00:00:00Z","timestamp":1403049600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00520-014-2309-x","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T10:47:42Z","timestamp":1403174862000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Patients\u2019 preferences for bone metastases treatments in France, Germany and the United Kingdom"],"prefix":"10.1007","volume":"23","author":[{"given":"Guy","family":"Hechmati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Brett","family":"Hauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ateesha F.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"von Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,18]]},"reference":[{"key":"2309_CR1","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s\u20136249s","journal-title":"Clin Cancer Res"},{"key":"2309_CR2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0959-8049(99)00331-7","volume":"36","author":"TA Plunkett","year":"2000","unstructured":"Plunkett TA, Smith P, Rubens RD (2000) Risk of complications from bone metastases in breast cancer: implications for management. Eur J Cancer 36:476\u2013482","journal-title":"Eur J Cancer"},{"key":"2309_CR3","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","volume":"48","author":"A Lipton","year":"2012","unstructured":"Lipton A, Fizazi K, Stopeck AT et al (2012) Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer 48:3082\u20133092","journal-title":"Eur J Cancer"},{"key":"2309_CR4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hec.1697","volume":"21","author":"EW Bekker-Grob de","year":"2012","unstructured":"de Bekker-Grob EW, Ryan M, Gerard K (2012) Discrete choice experiments in health economics: a review of the literature. Health Econ 21:145\u2013172","journal-title":"Health Econ"},{"key":"2309_CR5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/11539650-000000000-00000","volume":"3","author":"D Marshall","year":"2010","unstructured":"Marshall D, Bridges JFP, Hauber AB et al (2010) Conjoint analysis applications in health\u2014how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient 3:249\u2013256","journal-title":"Patient"},{"key":"2309_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/1312067-200801040-00009","volume":"1","author":"JFP Bridges","year":"2008","unstructured":"Bridges JFP, Kinter E, Kidane L, Heinzen RR, McCormick C (2008) Things are looking up since we started listening to patients. Patient 1:273\u2013282","journal-title":"Patient"},{"key":"2309_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JFP Bridges","year":"2011","unstructured":"Bridges JFP, Hauber AB, Marshall D et al (2011) Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 14:403\u2013411","journal-title":"Value Health"},{"key":"2309_CR8","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511610356","volume-title":"Applied choice analysis","author":"DA Hensher","year":"2005","unstructured":"Hensher DA, Rose JM, Greene WH (2005) Applied choice analysis. Cambridge University Press, Cambridge, UK"},{"key":"2309_CR9","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511753831","volume-title":"Stated choice methods: analysis and application","author":"JJ Louviere","year":"2000","unstructured":"Louviere JJ, Hensher DA, Swait J (2000) Stated choice methods: analysis and application. Cambridge University Press, Cambridge, UK"},{"key":"2309_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/09546634.2011.588193","volume":"22","author":"AB Hauber","year":"2011","unstructured":"Hauber AB, Gonzalez JM, Schenkel B, Lofland J, Martin S (2011) The value to patients of reducing lesion severity in plaque psoriasis. J Dermatol Treat 22:266\u2013275","journal-title":"J Dermatol Treat"},{"key":"2309_CR11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1524-4733.2010.00694.x","volume":"13","author":"FR Johnson","year":"2010","unstructured":"Johnson FR, Hauber AB, Ozdemir S, Lynd L (2010) Quantifying women\u2019s stated benefit-risk tradeoff preferences for IBS treatment outcomes. Value Health 13:418\u2013423","journal-title":"Value Health"},{"key":"2309_CR12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11136-010-9621-9","volume":"19","author":"AB Hauber","year":"2010","unstructured":"Hauber AB, Mohamed AF, Johnson FR, Oyelowo O, Curtis BH, Coon C (2010) Estimating importance weights for the IWQOL-Lite using conjoint analysis. Qual Life Res 19:701\u2013709","journal-title":"Qual Life Res"},{"key":"2309_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","volume":"16","author":"FR Johnson","year":"2013","unstructured":"Johnson FR, Lancsar E, Marshall D et al (2013) Constructing experimental designs for discrete-choice experiments: Report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health 16:3\u201313","journal-title":"Value Health"},{"key":"2309_CR14","volume-title":"Orthogonal fractional factorial designs","author":"A Dey","year":"1985","unstructured":"Dey A (1985) Orthogonal fractional factorial designs. Halstead Press, New York, USA"},{"key":"2309_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2307\/3152127","volume":"33","author":"J Huber","year":"1996","unstructured":"Huber J, Zwerina K (1996) The importance of utility balance in efficient choice designs. J Mark Res 33:307\u2013317","journal-title":"J Mark Res"},{"key":"2309_CR16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1509\/jmkr.39.2.214.19080","volume":"39","author":"B Kanninen","year":"2002","unstructured":"Kanninen B (2002) Optimal design for multinomial choice experiments. J Mark Res 39:214\u2013227","journal-title":"J Mark Res"},{"key":"2309_CR17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2307\/3151882","volume":"31","author":"W Kuhfeld","year":"1994","unstructured":"Kuhfeld W, Tobias F, Garratt M (1994) Efficient experimental design with marketing research applications. J Mark Res 31:545\u2013557","journal-title":"J Mark Res"},{"key":"2309_CR18","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511753930","volume-title":"Discrete choice methods with simulation","author":"K Train","year":"2003","unstructured":"Train K (2003) Discrete choice methods with simulation. Cambridge University Press, Cambridge, UK"},{"key":"2309_CR19","volume-title":"Applications of simulation methods in environmental and resource economics","author":"K Train","year":"2005","unstructured":"Train K, Sonnier G (2005) Mixed logit with bounded distributions of correlated partworths. In: Scarpa R, Alberini A (eds) Applications of simulation methods in environmental and resource economics. Springer Publisher, Dordrecht (Netherlands)"},{"key":"2309_CR20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2893.2010.01343.x","volume":"18","author":"AB Hauber","year":"2011","unstructured":"Hauber AB, Mohamed AF, Beam C, Medjedovic J, Mauskopf J (2011) Patient preferences and assessment of likely adherence for hepatitis C virus treatments. J Viral Hepat 18:619\u2013627","journal-title":"J Viral Hepat"},{"key":"2309_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.joca.2012.11.007","volume":"221","author":"AB Hauber","year":"2013","unstructured":"Hauber AB, Arden NK, Mohamed AF et al (2013) A discrete-choice experiment of United Kingdom patients\u2019 willingness to risk adverse events for improved function and pain control in osteoarthritis. Osteoarthr Cartil 221:289\u2013297","journal-title":"Osteoarthr Cartil"},{"key":"2309_CR22","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00520-013-1932-2","volume":"21","author":"R Moos Von","year":"2013","unstructured":"Von Moos R, Body JJ, Egerdie B et al (2013) Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer 21:3497\u20133507","journal-title":"Support Care Cancer"},{"key":"2309_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/CMAR.S27693","volume":"4","author":"A Richhariya","year":"2012","unstructured":"Richhariya A, Qian Y, Zhao Y, Chung K (2012) Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis. Cancer Manag Res 4:55\u201360","journal-title":"Cancer Manag Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2309-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2309-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2309-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:51:51Z","timestamp":1553640711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2309-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2309"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2309-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,18]]}}}